Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.

Vaccine(2015)

引用 9|浏览17
暂无评分
摘要
•A cell culture-derived influenza vaccine (NBP607) showed excellent long-term immunogenicity.•NBP607 had tolerable safety profiles with no significant difference compared to the egg-based vaccine.•NBP607 was more immunogenic against influenza B compared to the egg-based vaccine.
更多
查看译文
关键词
Influenza vaccines,Cell culture techniques,Influenza,Human,Vaccines,Inactivated
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要